$HZNP News Stocks are poised for a jump higher 12:30

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2014 at 10:18 AM

$HZNP News

Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
Two health-care names ready to run 12:28 p.m. June 5, 2014 - The Trading Deck
6 stocks to watch 3:13 p.m. June 4, 2014 - The Trading Deck
Charting a bullish second-quarter backdrop 12:34 p.m. April 1, 2014 - Michael Ashbaugh
Charting a bullish second-quarter backdrop 12:20 p.m. April 1, 2014 - Michael Ashbaugh
S&P 500 retests major support 12:47 p.m. March 27, 2014 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com

Why Horizon Pharma (HZNP) Could Be Positioned for a Surge? - Tale of the Tape 8:35 a.m. June 11, 2014 - Zacks.com
Horizon Pharma (HZNP) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape 9:42 a.m. June 2, 2014 - Zacks.com
Substance Over Style: How Niche Companies Alliqua And Horizon Are Being Overlooked 9:42 a.m. May 29, 2014 - Seeking Alpha
Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape 8:57 a.m. May 29, 2014 - Zacks.com
Hottest Healthcare Stocks Now – HZNP MNKD BSX ISIS 1:45 p.m. May 28, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – ISIS CLDX HZNP IDIX 7:45 a.m. May 27, 2014 - InvestorPlace.com
U.S. Firms Pack Up for Tax Benefits 7:36 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition
The 'Inversion' Premium 7:29 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition
Pozen, Inc.: Buy This Biotech For Growth And Income 9:13 a.m. May 10, 2014 - Seeking Alpha
Horizon Pharma's (HZNP) CEO Tim Walbert on Q1 2014 Results - Earnings Call Transcript 11:19 a.m. May 9, 2014 - Seeking Alpha
Horizon Pharma Q1 Beats Street; Guidance Mixed 10:12 a.m. May 9, 2014 - Investors Business Daily
Horizon set for an opening gap up 8:59 a.m. May 9, 2014 - Seeking Alpha
Horizon Pharma (HZNP) Q1 2014 Results - Earnings Call Webcast 7:55 a.m. May 9, 2014 - Seeking Alpha
10-Q: HORIZON PHARMA, INC. 7:04 a.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Horizon Pharma (HZNP) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape 7:18 a.m. May 1, 2014 - Zacks.com
Horizon Pharma Reports Inducement Grants 3:36 p.m. April 23, 2014 - benzinga.com
First Week Of June 21st Options Trading For Horizon Pharma (HZNP) 11:59 a.m. April 23, 2014 - TheStreet.com
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)? - Tale of the Tape 8:41 a.m. April 21, 2014 - Zacks.com
Horizon Pharma Announces Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Vidara Therapeutics International Ltd 6:31 a.m. April 16, 2014 - benzinga.com
Trade-Ideas: Horizon Pharma (HZNP) Is Today's "Perilous Reversal" Stock 9:46 a.m. April 10, 2014 - TheStreet.com

Consent Expiry Extensions, Collaborations, Grants, Conference Presentations, and FDA Approvals - Analyst Notes on Forest Laboratories, Intuitive Surgical, Horizon Pharma, Cubist and BDSI 6:10 a.m. Today - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:45 p.m. June 6, 2014 - Marketwire
Top Gainers Roundup -- Research on Horizon Pharma, Celldex Therapeutics, Extreme Networks, and WidePoint 6:17 a.m. May 28, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 27, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:10 p.m. May 23, 2014 - Marketwire
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Horizon Pharma Reports First Quarter 2014 Financial Results Exceeding Expectations and Raises 2014 Full-Year Guidance 6:31 a.m. May 9, 2014 - Marketwire
Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 9, 2014 7:30 a.m. April 25, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:35 p.m. April 23, 2014 - Marketwire
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 11:34 a.m. April 23, 2014 - PR Newswire - PRF
Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board of Directors 7:31 a.m. April 17, 2014 - Marketwire
Horizon Pharma Announces Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Vidara Therapeutics International Ltd. 7:30 a.m. April 16, 2014 - Marketwire
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 7:30 a.m. April 10, 2014 - Marketwire
Technical Data on Top Gainers -- Research on JinkoSolar, Horizon Pharma, YY Inc., and Questcor Pharma 9:59 a.m. April 2, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 10:20 p.m. March 27, 2014 - Marketwire
Acquisitions, Appointments, and New Product Developments - Analyst Notes on Boston Scientific, Horizon Pharma, Alkermes, Agilent, and BD 8:00 a.m. March 26, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the 21st Annual Future Leaders in the Biotech Industry Conference 7:31 a.m. March 25, 2014 - Marketwire
Horizon Pharma to Host Corporate Update Meeting on March 27, 2014 7:30 a.m. March 24, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Core Lab's Quarterly Grit: Navigating a Turbulent Market

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Infoya Surges with 665% Growth, Wins Fast 50 Spot

From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...

White House Photographer Reveals Unseen Historic Moments

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Doximity Faces Legal Heat: 23% Stock Plunge Analyzed

Doximity's Rollercoaster: Steep Drop Amid Lawsuits Imagine watching your portfolio take a gut-wrenching plunge—and that's the rollercoaster ride Doximity investors experienced. On May 14, 2026, Doximity's stock nosedived by 23%, closing at $18.01 per share. This tumble, which marked a painful conclusion to a series of financial disappointments, has thrown the company...

Xyte's Record Quarter: Surging Demand & New CEO

Setting New Records in the AV Industry There's buzz in the air over in Hoboken, New Jersey. Xyte, the AI cloud maestro you're starting to hear about more and more, has just smashed its own records this past September. It's not just a flash in the pan, either—this isn't the first time they've knocked it out of the park. Thanks to burgeoning enterprise demand and a...

Royce Micro-Cap Trust: Navigating Small-Cap Waves

Folks, if there's ever been a niche in this labyrinth of stocks, it’s the micro-cap territory. Royce Micro-Cap Trust (NYSE: RMT) is hefting the torch for smaller companies up to a billion in market cap. But is it leading the charge or getting steamrolled by market bear crawls? Understanding the Numbers Time to get dirty with some numbers, because for Royce Micro-Cap...

McKinsey and Parloa Join Forces on AI Customer Service

AI-Revolutionizing Customer Service: The New Partnership Out of the boardroom and into the trenches, McKinsey joins hands with Parloa, aiming to reshape how enterprises handle customer service through artificial intelligence. Forget all the corporate fluff you've heard before; these guys are dead set on closing the massive gap companies face in deploying AI agents...

BlueNord Signals Strategic Shift with Vår Energi Merger

BlueNord's Bold Move in the Energy Sector With the ink barely dry on their third-quarter results, BlueNord has dropped a bombshell: a merger approved with Vår Energi. This isn't just another page in their corporate books—it's a strategic pivot that could redefine their place within the oil and gas arena. Anybody keeping an eye on the energy sector right now should sit...

BetaNXT and Pave Finance Transform Wealth Management

AI Takes Center Stage in Wealth Management You know, it's not every day we see two powerhouses like BetaNXT and Pave Finance buddying up to shake up the financial advisory world. This partnership's all about harnessing AI to give wealth management firms and financial advisors some serious firepower in portfolio planning. BetaNXT, already a big name with its slick...

Storyteq's AI Edge Earns Gartner Leader Status Again

Pioneering AI in Digital Asset Management Alright, folks, this ain't just another tech release to gloss over with your morning coffee—ITG's Storyteq has snagged the 'Leader' title in Gartner's Magic Quadrant for Digital Asset Management. It's no small feat to earn such recognition three years running, and the secret sauce is their advanced AI capabilities. A Unified AI...